Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus
Introduction: The macromolecular complex formed by creatine phosphokinase (CPK) is most probably an immune complex. Most of the macro-CPK migrates between CPK-MM and CPK-MB, exhibiting an atypical band on isozyme electrophoresis. Either IgA or IgG has been identified with its CPK link (termed as mac...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2022-05-01
|
| Series: | Dubai Diabetes and Endocrinology Journal |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/524604 |
| _version_ | 1826953278949163008 |
|---|---|
| author | Koji Kikkawa Kazuya Okada Junichi Okada Kihachi Ohshima Shuichi Okada |
| author_facet | Koji Kikkawa Kazuya Okada Junichi Okada Kihachi Ohshima Shuichi Okada |
| author_sort | Koji Kikkawa |
| collection | DOAJ |
| description | Introduction: The macromolecular complex formed by creatine phosphokinase (CPK) is most probably an immune complex. Most of the macro-CPK migrates between CPK-MM and CPK-MB, exhibiting an atypical band on isozyme electrophoresis. Either IgA or IgG has been identified with its CPK link (termed as macro-CPK type 1). However, the biological and pathological significance of these complexes found in patients with wide-ranging disease states remains unclear. Herein, we first report a case of type 2 diabetes mellitus associated with hypercreatinekinasemia caused by macro-CPK type 1, with CPK levels negatively correlated with blood glucose control. Case Presentation: A 53-year-old Japanese woman with no complaints of muscle weakness, myalgia, and numbness of the extremities was diagnosed with hypercreatinekinasemia. Over the past years, she received empagliflozin, mitiglinide, voglibose, vildagliptin, metformin, methyl thiazide, and ezetimibe. Serum biochemistry revealed elevated CPK levels. The highest CPK value was 1,063 U/L, and the three major isozymes CPK-BB, CPK-MB, and CPK-MM accounted for 0%, 2%, and 98%, respectively. Notably, CPK isozyme electrophoresis performed on a cellulose acetate membrane detected an additional band that migrated between the CPK-MB and CPK-MM bands, suggesting macro-CPK type 1, which occupied 82% of the total CPK. The densitometric profile of the electrophoresis pattern revealed that CPK-BB, CPK-MB, and CPK-MM constituted 0%, 2%, and 16%, respectively. Moreover, serum CPK levels combined with macro-CPK showed a significant negative correlation with the HbA1c values (r = −0.498, p < 0.001). Conclusions: Serum CPK levels accompanied with macro-CPK type 1 negatively correlate with plasma glucose control. Although the pathophysiological role of macro-CPK remains unclear, our case report may provide a new viewpoint regarding macro-CPK etiology. |
| first_indexed | 2024-04-12T13:17:07Z |
| format | Article |
| id | doaj.art-1d731207757c4c13b0c6eca64956cee1 |
| institution | Directory Open Access Journal |
| issn | 2673-1797 2673-1738 |
| language | English |
| last_indexed | 2025-02-17T23:18:37Z |
| publishDate | 2022-05-01 |
| publisher | Knowledge E |
| record_format | Article |
| series | Dubai Diabetes and Endocrinology Journal |
| spelling | doaj.art-1d731207757c4c13b0c6eca64956cee12024-12-02T06:16:11ZengKnowledge EDubai Diabetes and Endocrinology Journal2673-17972673-17382022-05-01282697310.1159/000524604524604Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes MellitusKoji Kikkawa0Kazuya Okada1Junichi Okada2Kihachi Ohshima3Shuichi Okada4Department of Diabetes and Endocrinology, Hidaka Hospital, Gunma, JapanOmagari Kousei Medical Center, Akita, JapanDivision of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USADepartment of Diabetes and Endocrinology, Hidaka Hospital, Gunma, JapanDepartment of Diabetes and Endocrinology, Hidaka Hospital, Gunma, JapanIntroduction: The macromolecular complex formed by creatine phosphokinase (CPK) is most probably an immune complex. Most of the macro-CPK migrates between CPK-MM and CPK-MB, exhibiting an atypical band on isozyme electrophoresis. Either IgA or IgG has been identified with its CPK link (termed as macro-CPK type 1). However, the biological and pathological significance of these complexes found in patients with wide-ranging disease states remains unclear. Herein, we first report a case of type 2 diabetes mellitus associated with hypercreatinekinasemia caused by macro-CPK type 1, with CPK levels negatively correlated with blood glucose control. Case Presentation: A 53-year-old Japanese woman with no complaints of muscle weakness, myalgia, and numbness of the extremities was diagnosed with hypercreatinekinasemia. Over the past years, she received empagliflozin, mitiglinide, voglibose, vildagliptin, metformin, methyl thiazide, and ezetimibe. Serum biochemistry revealed elevated CPK levels. The highest CPK value was 1,063 U/L, and the three major isozymes CPK-BB, CPK-MB, and CPK-MM accounted for 0%, 2%, and 98%, respectively. Notably, CPK isozyme electrophoresis performed on a cellulose acetate membrane detected an additional band that migrated between the CPK-MB and CPK-MM bands, suggesting macro-CPK type 1, which occupied 82% of the total CPK. The densitometric profile of the electrophoresis pattern revealed that CPK-BB, CPK-MB, and CPK-MM constituted 0%, 2%, and 16%, respectively. Moreover, serum CPK levels combined with macro-CPK showed a significant negative correlation with the HbA1c values (r = −0.498, p < 0.001). Conclusions: Serum CPK levels accompanied with macro-CPK type 1 negatively correlate with plasma glucose control. Although the pathophysiological role of macro-CPK remains unclear, our case report may provide a new viewpoint regarding macro-CPK etiology.https://www.karger.com/Article/FullText/524604hba1ctype 2 diabetes mellitushypercreatinekinasemiamacromolecular cpk type 1 |
| spellingShingle | Koji Kikkawa Kazuya Okada Junichi Okada Kihachi Ohshima Shuichi Okada Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus Dubai Diabetes and Endocrinology Journal hba1c type 2 diabetes mellitus hypercreatinekinasemia macromolecular cpk type 1 |
| title | Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus |
| title_full | Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus |
| title_fullStr | Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus |
| title_full_unstemmed | Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus |
| title_short | Creatine Phosphokinase Level Accompanied with Macro-Creatine Phosphokinase Type 1 Negatively Correlates with Plasma Glucose Control in a Patient with Type 2 Diabetes Mellitus |
| title_sort | creatine phosphokinase level accompanied with macro creatine phosphokinase type 1 negatively correlates with plasma glucose control in a patient with type 2 diabetes mellitus |
| topic | hba1c type 2 diabetes mellitus hypercreatinekinasemia macromolecular cpk type 1 |
| url | https://www.karger.com/Article/FullText/524604 |
| work_keys_str_mv | AT kojikikkawa creatinephosphokinaselevelaccompaniedwithmacrocreatinephosphokinasetype1negativelycorrelateswithplasmaglucosecontrolinapatientwithtype2diabetesmellitus AT kazuyaokada creatinephosphokinaselevelaccompaniedwithmacrocreatinephosphokinasetype1negativelycorrelateswithplasmaglucosecontrolinapatientwithtype2diabetesmellitus AT junichiokada creatinephosphokinaselevelaccompaniedwithmacrocreatinephosphokinasetype1negativelycorrelateswithplasmaglucosecontrolinapatientwithtype2diabetesmellitus AT kihachiohshima creatinephosphokinaselevelaccompaniedwithmacrocreatinephosphokinasetype1negativelycorrelateswithplasmaglucosecontrolinapatientwithtype2diabetesmellitus AT shuichiokada creatinephosphokinaselevelaccompaniedwithmacrocreatinephosphokinasetype1negativelycorrelateswithplasmaglucosecontrolinapatientwithtype2diabetesmellitus |